Advertisement Press Releases Archive - Page 109 of 231 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressreleases

  • Malvern Instruments Zetasizer Nano Plays Key Role in Research to Develop 3D Cell Cultures

    Researchers at the School of Engineering and Materials Science, Queen Mary University London (QMUL), are using a Malvern Instruments Zetasizer Nano to provide particle size and charge data that is being used in the development of innovative hydrogel matrices for 3D cell culture. The Zetasizer Nano’s high performance electrophoretic light scattering capabilities are allowing researchers to better understand the nature of the electrostatic interactions between proteins and peptides. These measurements are crucial to developing bespoke cell culture platforms for the production of specific biologically significant hydrogel.

  • CurTec Launches XL Nestable Drums

    CurTec’s successful line of nestable drums is set to be expanded with the introduction of two new capacities. The 75 and 115l (20 and 30 US gal) drums will fill the product line upwards. The new 115l nestable drum is now the largest capacity in the entire CurTec packaging range.

  • Sartorius Opens New Application Centre in Shanghai

    Sartorius, a leading international laboratory and pharmaceutical equipment supplier, officially opened a new application centre at its Shanghai office last week. Among the guests, representatives from the Shanghai government, customers from the biopharmaceutical industry as well as business partners and the media attended the opening ceremony.

  • Haselmeier announces the launch of INSUPen® EZ in India by Biocon

    Haselmeier announces that Biocon, one of Asia’s premier biotechnology companies, has just launched INSUPen® EZ in India. The INSUPen EZ is a second generation pen and follows on the success of Biocon’s premier insulin delivery device INSUPen®. Under the terms of the agreement between the two companies, Biocon has worldwide distribution rights to INSUPen®
    EZ, for use with Biocon’s insulin, Basalog™ and Insugen™, and insulin analogues.

  • CEO of IPERION will speak at the ECA GMP Course March 2015

    CEO Karel Bastiaanssen will give two presentations at the ECA GMP Course Cloud Computing and Outsourcing in a GxP Environment. The course will take place 12-13 March in Berlin, Germany, where the cloud service provider business and operating as a cloud service provider will be highlighted.

  • Cloud Computing and Outsourcing in a GxP Environment

    As well as in other sectors, the use of cloud computing is discussed in the pharmaceutical industry. For commercial reasons there is a lot speaking for the use. However, is cloud computing an acceptable way in a GxP environment of the pharmaceutical industry? And, if yes, what has to be observed from the point of view of IT and quality assurance, as well as from the perspective of a pharmaceutical inspector? From the points of view of the user and the pharmaceutical inspector this event gives you an overview of the current state of the technical possibilities. The speakers evaluate opportunities and risks of the use of cloud computing in the GxP environment and make recommendations for the pharmaceutical practice.